| Li, Di |
FOCUS, NCT06485427: Safety and Efficacy of Selective Intra-Arterial Cooling Infusion Combined With EVT in Acute Ischemic Stroke |
|
|
| Recruiting | N/A | 258 | RoW | Selective Intra-arterial Cooling Infusion (IA-SCI) | Beijing Shijitan Hospital, Capital Medical University | Acute Ischemic Stroke, Hypothermia | 06/26 | 08/26 | | |
| Qiu, chunguang |
| Completed | N/A | 980 | RoW | Rotational Atherectomy | Beijing Anzhen Hospital, BSC International Medical Trading (Shanghai) Co., Ltd. | Coronary Artery Disease | 12/20 | 01/22 | | |
| Not yet recruiting | N/A | 306 | NA | extracorporeal membrane oxygenation, intra-aortic balloon pump | Xijing Hospital, The First Affiliated Hospital of Zhengzhou University, Bethune International Peace Hospital, Beijing Anzhen Hospital, The Second Affiliated Hospital of Harbin Medical University, The General Hospital of Northern Theater Command | Coronary Artery Disease, Heart Failure | 07/21 | 06/24 | | |
NCT04569669: The Sensitivity and Specificity of CardioSimFFRct Analysis Software on Coronary Artery Stenosis |
|
|
| Not yet recruiting | N/A | 325 | RoW | FFR and FFRCT | CCRF Inc., Beijing, China, Shengshi Technology, Co., Ltd, Hangzhou, China | Coronary Stenosis | 10/21 | 03/22 | | |
SIBLINT ISR, NCT04240444: Sirolimus-Coated Balloon Versus Paclitaxel-Coated Balloon for the Treatment of Coronary In-Stent Restenosis |
|
|
| Completed | N/A | 260 | RoW | drug-coated balloon Catheter | B. Braun Medical International Trading Company Ltd., CCRF Inc., Beijing, China | Coronary Artery Disease, In Stent Restenosis | 07/22 | 08/22 | | |
NCT06365502: Preventive Drug-coated Balloon Angioplasty in Vulnerable Atherosclerotic Plaque (RESTORE Trial) |
|
|
| Recruiting | N/A | 1860 | RoW | Drug-coated balloon, Guideline-directed medical treatment | Harbin Medical University, Shanghai Shenqi Medical Technology Co., Ltd | Acute Coronary Syndrome (ACS) | 12/27 | 12/30 | | |
LEAP-Block, NCT04730921: Impact of Left Bundle Branch Area Pacing vs. Right Ventricular Pacing in Atrioventricular Block |
|
|
| Recruiting | N/A | 458 | RoW | Left bundle branch area pacing, Right ventricular pacing | Fu Wai Hospital, Beijing, China, Beijing Anzhen Hospital, The First Affiliated Hospital of Zhengzhou University, The Second Hospital of Hebei Medical University, Fuwai Central China Cardiovascular Hospital, Tianjin Medical University General Hospital, Teda International Cardiovascular Hospital, Tianjin, China, Peking Union Medical College Hospital, Chinese Society of Cardiology, Affiliated Hospital of Qinghai University, Shanxi Cardiovascular Hospital, First Affiliated Hospital of Chongqing Medical University, Peking University First Hospital, Beijing Friendship Hospital | Atrioventricular Block, Left Bundle Branch Area Pacing, Right Ventricular Pacing, Heart Failure | 06/24 | 12/25 | | |
| Pan, Xiaofang |
NCT05455099: A Multicenter Study of Ultrafast Pulse Wave Velocity in Obese Chinese Han Adults |
|
|
| Recruiting | N/A | 2400 | RoW | Carotid ultrasound examination 1, Carotid ultrasound examination 2 | First Hospital of China Medical University | Carotid Artery Diseases | 08/23 | 07/24 | | |
| Cai |
JACKPOT8, NCT04105010: Assessing An Oral Janus Kinase Inhibitor, AZD4205 as Monotherapy in Patients Who Have PTCL |
|
|
| Completed | 2 | 171 | US, RoW | AZD4205 | Dizal Pharmaceuticals | Relapsed or Refractory Peripheral T Cell Lymphoma | 10/23 | 02/24 | | |
| Guo, Wenbin |
NCT04136782: Albumin-bound Paclitaxel and Carboplatin Versus Epirubicin and Docetaxel for Triple-negative Breast Cancer |
|
|
| Recruiting | 4 | 110 | RoW | Albumin-bound paclitaxel combined with carboplatin, Albumin-bound paclitaxel+carboplatin group, Epirubicin combined with docetaxel, Epirubicin+docetaxel group | Shengjing Hospital | Breast Cancer | 11/25 | 11/26 | | |
NCT06452953: Modified Suanzaoren Decoction Versus Eszopiclone for the Treatment of Chronic Insomnia Disorder |
|
|
| Completed | N/A | 85 | RoW | suanzaoren decoction, Suan Zao Ren Tang, Eszopiclone 1 mg, Estorra | Central South University, The Third Hospital of Inner Mongolia Autonomous Region | Chronic Insomnia Disorder | 10/23 | 03/24 | | |
NCT04476485: Sj-subway, a Predictor for the Recurrence of High-risk Hormone Receptor-positive Breast That is Sensitive to Extended Endocrine Therapy |
|
|
| Recruiting | N/A | 1000 | RoW | endocrine therapy | Shengjing Hospital | Breast Cancer | 12/21 | 12/26 | | |
NCT04977232: Adjunctive Game Intervention for Anhedonia in MDD Patients |
|
|
| Completed | N/A | 50 | RoW | Escitalopram, Lexapro, Game intervention | Central South University | Depression | 12/22 | 12/22 | | |
NCT03894085: Definitive Selection of Neuroimaging Biomarkers in Anxiety Disorder and Obsessive-compulsive Disorder: A Longitudinal Functional Magnetic Resonance Imaging （fMRI） Study With Paroxetine Treatment |
|
|
| Completed | N/A | 150 | RoW | Paroxetine | Central South University | Anxiety Disorder, Obsessive-Compulsive Disorder | 12/22 | 12/22 | | |
NCT04218981: Definitive Selection of Neuroimaging Biomarkers for the Diagnosis and Treatment to Common Mental Disorders |
|
|
| Completed | N/A | 200 | RoW | Antipsychotic drugs, MRI scan, Mood stabilizer, Paroxetine | Central South University | Common Mental Disorder | 06/23 | 12/23 | | |
NCT05039489: A Study on the Brain Mechanism of cTBS in Improving Medication-resistant Auditory Hallucinations in Schizophrenia |
|
|
| Completed | N/A | 200 | RoW | Antipsychotic drugs, MRI scan, cTBS（the left temporoparietal cortex as the stimulation target）, cTBS （the left cerebellum Crus II as the stimulation target） | Central South University | Schizophrenia | 10/23 | 11/23 | | |
| Tu, Wei |
| Recruiting | 4 | 20 | RoW | Mycophenolate mofetil combined with oral prednisone | Tongji Hospital | Rosai-Dorfman Disease, Langerhans Cell Histiocytosis | 06/22 | 06/22 | | |
NCT05303285: A Study Evaluating the Efficacy of Secukinumab 300mg in Chinese Adults With Active Ankylosing Spondylitis |
|
|
| Recruiting | 4 | 100 | RoW | Secukinumab 300mg s.c., AIN457, Cosentyx, Secukinumab 150mg s.c. | Tongji Hospital, Wuhan Central Hospital, Wuhan Hospital of Traditional Chinese Medicine | Ankylosing Spondylitis (AS) | 08/22 | 08/22 | | |
NCT05303272: A Study to Evaluate Efficacy and Safety of Abatacept in Participants of Pemphigus Vulgaris (PV) |
|
|
| Recruiting | 4 | 60 | RoW | Abatacept Prefilled Syringe, Orencia, Mycophenolate Mofetil 500Mg Tab, MMF,CellCept | Tongji Hospital, Wuhan Central Hospital, Wuhan Hospital of Traditional Chinese Medicine | Pemphigus Vulgaris | 09/22 | 09/22 | | |
NCT05300932: A Study Evaluating the Efficacy and Safety of Baricitinib in Systemic Sclerosis |
|
|
| Recruiting | 4 | 60 | RoW | Baricitinib, Olumiant, Cyclophosphamide, Cytoxan | Tongji Hospital | Systemic Sclerosis | 03/23 | 04/23 | | |
NCT04136782: Albumin-bound Paclitaxel and Carboplatin Versus Epirubicin and Docetaxel for Triple-negative Breast Cancer |
|
|
| Recruiting | 4 | 110 | RoW | Albumin-bound paclitaxel combined with carboplatin, Albumin-bound paclitaxel+carboplatin group, Epirubicin combined with docetaxel, Epirubicin+docetaxel group | Shengjing Hospital | Breast Cancer | 11/25 | 11/26 | | |
NCT04476485: Sj-subway, a Predictor for the Recurrence of High-risk Hormone Receptor-positive Breast That is Sensitive to Extended Endocrine Therapy |
|
|
| Recruiting | N/A | 1000 | RoW | endocrine therapy | Shengjing Hospital | Breast Cancer | 12/21 | 12/26 | | |
| Xia, Bing-Shu |
NCT04476485: Sj-subway, a Predictor for the Recurrence of High-risk Hormone Receptor-positive Breast That is Sensitive to Extended Endocrine Therapy |
|
|
| Recruiting | N/A | 1000 | RoW | endocrine therapy | Shengjing Hospital | Breast Cancer | 12/21 | 12/26 | | |
| Guo, Wen-Bin |
NCT04476485: Sj-subway, a Predictor for the Recurrence of High-risk Hormone Receptor-positive Breast That is Sensitive to Extended Endocrine Therapy |
|
|
| Recruiting | N/A | 1000 | RoW | endocrine therapy | Shengjing Hospital | Breast Cancer | 12/21 | 12/26 | | |
| Fang, Hong |
| Recruiting | 4 | 180 | RoW | Ephedrine-P, vasopressor, Phenylephrine-P, Norepinephrine-P, Ephedrine-S, Phenylephrine-S, Norepinephrine-S | Dalian Municipal Central Hospital | Hypotension Drug-Induced | 12/25 | 12/25 | | |
NCT04875169: Evaluate Efficacy and Safety of Oral SHR0302 in Subjects Aged 12 Years and Older With Moderate to Severe Atopic Dermatitis |
|
|
| Completed | 3 | 336 | Canada, RoW | Core Treatment Active Experimental: SHR0302 Dose#1, Core Treatment Active Experimental: SHR0302 Dose#2, Core Treatment Placebo Comparator: Placebo, Extension Treatment Active Experimental: SHR0302 Dose#1, Extension Treatment Active Experimental: SHR0302 Dose#2 | Reistone Biopharma Company Limited | Atopic Dermatitis | 08/22 | 05/23 | | |
NCT04851613: Study Evaluating Efficacy & Safety of Afuresertib Plus Fulvestrant in Patients w/ Locally Advanced or Metastatic HR+/HER2- Breast Cancer |
|
|
| Recruiting | 3 | 256 | US, RoW | Afuresertib, Fulvestrant, Afuresertib/placebo | Laekna Limited | Breast Cancer | 10/26 | 12/26 | | |
NCT05702268: Pharmacodynamic Blood Characteristics of ICP-332 in Patients With Moderate to Severe Atopic Dermatitis |
|
|
| Recruiting | 2 | 75 | RoW | ICP-332, ICP-332 Placebo | Beijing InnoCare Pharma Tech Co., Ltd. | Moderate to Severe Atopic Dermatitis | 07/23 | 12/23 | | |
NCT06133088: Dalpiciclib Combination With Fulvestrant and Compound Gossyfol Acetate Tablets in Women With CDK4/6 Inhibitor-refractory HR-positive HER-2 Negtive Metastatic Breast Cancer: a Phase 2 Clinical Trial. |
|
|
| Recruiting | 2 | 53 | RoW | dalpiciclib; fluvestrant; compound gossypol acetate tablets | Zhejiang Cancer Hospital | Advanced HR-positive and HER2-negative Breast Cancer; CDK4/6 Inhibitor Treatment Failed | 12/24 | 08/25 | | |
NCT04912401: the Efficacy and Safety of Etanercept （Yi Sai Pu) in Chinese Patients With Moderate-to-Severe Psoriasis |
|
|
| Recruiting | N/A | 100 | RoW | | Second Affiliated Hospital, School of Medicine, Zhejiang University | Psoriasis, Etanercept | 12/25 | 12/25 | | |
| Yue, Qingxiong |
NCT06282796: Early Prediction and Warning for Cardiotoxicity Due to Anthracycline-Based Breast Cancer Chemotherapy |
|
|
| Recruiting | N/A | 600 | RoW | Echocardiography | First Hospital of China Medical University | Breast Cancer | 12/26 | 12/28 | | |
MET-LVH, NCT05719337: Multi-Modality Echocardiographic Techniques in Pathological Left Ventricular Hypertrophy Adults |
|
|
| Recruiting | N/A | 660 | RoW | Echocardiography | First Hospital of China Medical University, Wuhan Union Hospital, China | Left Ventricular Hypertrophy | 08/24 | 08/25 | | |
NOVAEA-HFUS, NCT05970926: Normal Reference Values in Han Adults of Extremity Arterial Structure and Hemodynamics by High-frequency Ultrasound |
|
|
| Not yet recruiting | N/A | 540 | NA | high-frequency ultrasound | First Hospital of China Medical University | Healthy Volunteer, Artery Disease | 08/24 | 08/25 | | |
NOVAS-HFUS, NCT06000163: Normal Reference Values in Han Adults of Skin Thickness and Blood Flow by High-frequency Ultrasound |
|
|
| Not yet recruiting | N/A | 540 | NA | high-frequency ultrasound | First Hospital of China Medical University | Healthy Volunteer, Skin | 09/24 | 09/25 | | |
| Su, Fanfan |
FOCUS, NCT06485427: Safety and Efficacy of Selective Intra-Arterial Cooling Infusion Combined With EVT in Acute Ischemic Stroke |
|
|
| Recruiting | N/A | 258 | RoW | Selective Intra-arterial Cooling Infusion (IA-SCI) | Beijing Shijitan Hospital, Capital Medical University | Acute Ischemic Stroke, Hypothermia | 06/26 | 08/26 | | |
| Recruiting | N/A | 1332 | RoW | The lying flat (0°-10°) head position for 72 hours, The The head elevation (30°-40°) position for 72 hours | Zhengzhou Yuan | Stroke, Acute, Endovascular Therapy | 11/25 | 04/26 | | |
| Han, Liping |
| Recruiting | 4 | 180 | RoW | Ephedrine-P, vasopressor, Phenylephrine-P, Norepinephrine-P, Ephedrine-S, Phenylephrine-S, Norepinephrine-S | Dalian Municipal Central Hospital | Hypotension Drug-Induced | 12/25 | 12/25 | | |
| Not yet recruiting | 3 | 420 | RoW | Anlotinib hydrochloride capsule + TQB2450 injection, Chemotherapy drug | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | Endometrial Cancer | 12/27 | 06/29 | | |
| Yang, Guangyuan |
NCT06365502: Preventive Drug-coated Balloon Angioplasty in Vulnerable Atherosclerotic Plaque (RESTORE Trial) |
|
|
| Recruiting | N/A | 1860 | RoW | Drug-coated balloon, Guideline-directed medical treatment | Harbin Medical University, Shanghai Shenqi Medical Technology Co., Ltd | Acute Coronary Syndrome (ACS) | 12/27 | 12/30 | | |
